Literature DB >> 32425373

Approach to the Diagnosis of Amyloidosis.

Richa Juneja1, H P Pati1.   

Abstract

Amyloidosis is heterogeneous group of disorder characterized by extracellular deposition of misfolded insoluble proteinaceous material with cross beta pleated sheet structure leading to organ dysfunction. This disease is rare and indeed heterogeneous, as it may be hereditary (familial amyloidosis), secondary to spectrum of inflammatory conditions (AA amyloidosis) or member of plasma cell neoplasm family (AL amyloidosis). AL amyloidosis is the most common type of amyloid, however, is rarely accompanied by multiple myeloma or other lymphoproliferative disorder. This disparity in its origin and presentation needs to be addressed by exhaustive battery of investigation tools, to arrive at right diagnosis with correct typing. This is of utmost importance in guiding the treating physicians to choose appropriate therapeutic options. This review deals with diagnostic approach to amyloidosis and its various subtypes. © Indian Society of Hematology and Blood Transfusion 2019.

Entities:  

Keywords:  AA amyloid; AL amyloid; Amyloidosis; Cross beta pleated; Multiple myeloma; Proteinaceous

Year:  2019        PMID: 32425373      PMCID: PMC7229097          DOI: 10.1007/s12288-019-01208-4

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  20 in total

Review 1.  Review: history of the amyloid fibril.

Authors:  J D Sipe; A S Cohen
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

Review 2.  How to diagnose amyloidosis.

Authors:  P Mollee; P Renaut; D Gottlieb; H Goodman
Journal:  Intern Med J       Date:  2014-01       Impact factor: 2.048

3.  Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue.

Authors:  Francesca Brambilla; Francesca Lavatelli; Dario Di Silvestre; Veronica Valentini; Rossana Rossi; Giovanni Palladini; Laura Obici; Laura Verga; Pierluigi Mauri; Giampaolo Merlini
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

4.  A practical approach to the diagnosis of systemic amyloidoses.

Authors:  Carlos Fernández de Larrea; Laura Verga; Patrizia Morbini; Catherine Klersy; Francesca Lavatelli; Andrea Foli; Laura Obici; Paolo Milani; Gian Luca Capello; Marco Paulli; Giovanni Palladini; Giampaolo Merlini
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

Review 5.  Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Authors:  Morie A Gertz; Ray Comenzo; Rodney H Falk; Jean Paul Fermand; Bouke P Hazenberg; Philip N Hawkins; Giampaolo Merlini; Philippe Moreau; Pierre Ronco; Vaishali Sanchorawala; Orhan Sezer; Alan Solomon; Giles Grateau
Journal:  Am J Hematol       Date:  2005-08       Impact factor: 10.047

6.  Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.

Authors:  Stefan O Schönland; Ute Hegenbart; Tilmann Bochtler; Anja Mangatter; Marion Hansberg; Anthony D Ho; Peter Lohse; Christoph Röcken
Journal:  Blood       Date:  2011-11-21       Impact factor: 22.113

7.  A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.

Authors:  R A Kyle; M A Gertz; P R Greipp; T E Witzig; J A Lust; M Q Lacy; T M Therneau
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

8.  Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

Authors:  Helen J Lachmann; David R Booth; Susanne E Booth; Alison Bybee; Janet A Gilbertson; Julian D Gillmore; Mark B Pepys; Philip N Hawkins
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

Review 9.  Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management.

Authors:  S Vincent Rajkumar
Journal:  Am J Hematol       Date:  2016-07       Impact factor: 10.047

10.  How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.

Authors:  Nelson Leung; Samih H Nasr; Sanjeev Sethi
Journal:  Blood       Date:  2012-09-04       Impact factor: 22.113

View more
  1 in total

Review 1.  Renal amyloidosis: a new time for a complete diagnosis.

Authors:  V A Feitosa; P D M M Neves; L B Jorge; I L Noronha; L F Onuchic
Journal:  Braz J Med Biol Res       Date:  2022-10-03       Impact factor: 2.904

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.